David M.  Demski net worth and biography

David Demski Biography and Net Worth

David Demski has been Globus Medical’s President and Chief Executive Officer since August 2017. He previously served as our Chief Financial Officer from 2003 to July 2008 and as the President, Emerging Technologies. Prior to joining Globus Mr. Demski founded Cornerstone Capital LBO Fund, a boutique leveraged buyout consultancy. Mr. Demski’s experience also includes serving as Vice President for Gilo Ventures, a Silicon Valley-based venture capital fund, and serving as Chief Operating Officer of Rendall and Associates, a telecommunications-focused consulting firm. He also managed regional and international distribution for Domino’s Pizza during the company’s growth in the late 1980s. Previously he was an audit supervisor for Peat, Marwick, Mitchell & Company. Mr. Demski also serves on the Board of Directors of Axonics Modulation Technologies, Inc. (NASDAQ: AXNX). Mr. Demski received a B.S. in Business Administration from the University of Michigan and an M.B.A. from Stanford Graduate School of Business.

What is David M. Demski's net worth?

The estimated net worth of David M. Demski is at least $9.75 million as of November 9th, 2023. Mr. Demski owns 181,694 shares of Globus Medical stock worth more than $9,747,883 as of March 29th. This net worth evaluation does not reflect any other investments that Mr. Demski may own. Learn More about David M. Demski's net worth.

How do I contact David M. Demski?

The corporate mailing address for Mr. Demski and other Globus Medical executives is 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA, 19403. Globus Medical can also be reached via phone at (610) 930-1800 and via email at [email protected]. Learn More on David M. Demski's contact information.

Has David M. Demski been buying or selling shares of Globus Medical?

David M. Demski has not been actively trading shares of Globus Medical during the last ninety days. Most recently, David M. Demski sold 144,263 shares of the business's stock in a transaction on Monday, April 26th. The shares were sold at an average price of $71.50, for a transaction totalling $10,314,804.50. Following the completion of the sale, the chief executive officer now directly owns 21,875 shares of the company's stock, valued at $1,564,062.50. Learn More on David M. Demski's trading history.

Who are Globus Medical's active insiders?

Globus Medical's insider roster includes David Davidar (Director), David Demski (CEO), Robert Douglas (Director), Kelly Huller (SVP), Dan Lemaitre (Director), Keith Pfeil (CFO), Daniel Scavilla (EVP), and James Tobin (Director). Learn More on Globus Medical's active insiders.

Are insiders buying or selling shares of Globus Medical?

During the last year, insiders at the medical device company sold shares 2 times. They sold a total of 54,040 shares worth more than $3,026,355.10. The most recent insider tranaction occured on March, 15th when Director Leslie V Norwalk sold 10,590 shares worth more than $550,574.10. Insiders at Globus Medical own 24.3% of the company. Learn More about insider trades at Globus Medical.

Information on this page was last updated on 3/15/2024.

David M. Demski Insider Trading History at Globus Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/26/2021Sell144,263$71.50$10,314,804.5021,875View SEC Filing Icon  
4/23/2021Sell121,259$71.59$8,680,931.8121,875View SEC Filing Icon  
12/16/2020Sell52,356$64.20$3,361,255.20151,980View SEC Filing Icon  
4/19/2018Sell149,109$51.00$7,604,559.00192,018View SEC Filing Icon  
4/13/2018Sell50,891$51.00$2,595,441.00152,701View SEC Filing Icon  
11/1/2013Sell112,677$18.59$2,094,665.43View SEC Filing Icon  
8/8/2012Sell98,957$11.16$1,104,360.12View SEC Filing Icon  
See Full Table

David M. Demski Buying and Selling Activity at Globus Medical

This chart shows David M Demski's buying and selling at Globus Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Globus Medical Company Overview

Globus Medical logo
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Read More

Today's Range

Now: $53.65
Low: $52.77
High: $53.98

50 Day Range

MA: $53.68
Low: $51.15
High: $56.52

2 Week Range

Now: $53.65
Low: $43.38
High: $62.88

Volume

764,336 shs

Average Volume

1,181,863 shs

Market Capitalization

$7.26 billion

P/E Ratio

45.86

Dividend Yield

N/A

Beta

1.09